stoxline Quote Chart Rank Option Currency Glossary
  
Acutus Medical, Inc. (AFIB)
0.2188  -0.004 (-1.75%)    02-23 16:00
Open: 0.2159
High: 0.2188
Volume: 639,636
  
Pre. Close: 0.2227
Low: 0.1977
Market Cap: 6(M)
Technical analysis
2024-02-23 4:34:49 PM
Short term     
Mid term     
Targets 6-month :  0.38 1-year :  0.5
Resists First :  0.32 Second :  0.43
Pivot price 0.19
Supports First :  0.15 Second :  0.13
MAs MA(5) :  0.21 MA(20) :  0.2
MA(100) :  0.32 MA(250) :  0.6
MACD MACD :  0 Signal :  -0.1
%K %D K(14,3) :  45.5 D(3) :  52.7
RSI RSI(14): 53.6
52-week High :  1.59 Low :  0.15
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AFIB ] has closed below upper band by 21.4%. Bollinger Bands are 59.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.22 - 0.22 0.22 - 0.22
Low: 0.2 - 0.2 0.2 - 0.2
Close: 0.22 - 0.22 0.22 - 0.22
Company Description

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Headline News

Sat, 24 Feb 2024
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding - Simply Wall St

Wed, 20 Dec 2023
Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower - Simply Wall St

Thu, 09 Nov 2023
Medtronic's Manufacturing Partner Acutus Medical Exits Electrophysiology Mapping, Ablation Businesses - A - Benzinga

Wed, 08 Nov 2023
Acutus Medical to cut 65% of workforce, focus on Medtronic contracts (AFIB) - Seeking Alpha

Wed, 08 Nov 2023
Acutus Medical is laying off more than half of its workers - Mass Device

Wed, 08 Nov 2023
Acutus Medical Inc (AFIB) Reports Substantial Revenue Growth in Q3 2023 Despite Negative Gross ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 29 (M)
Shares Float 23 (M)
Held by Insiders 4.2 (%)
Held by Institutions 23.6 (%)
Shares Short 1,370 (K)
Shares Short P.Month 118 (K)
Stock Financials
EPS -1.13
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.08
Profit Margin -166.9 %
Operating Margin -297.6 %
Return on Assets (ttm) -45.1 %
Return on Equity (ttm) -73.3 %
Qtrly Rev. Growth 43.7 %
Gross Profit (p.s.) 0
Sales Per Share 0.67
EBITDA (p.s.) -2.28
Qtrly Earnings Growth 0 %
Operating Cash Flow -58 (M)
Levered Free Cash Flow -49 (M)
Stock Valuations
PE Ratio -0.2
PEG Ratio 0
Price to Book value 0.2
Price to Sales 0.32
Price to Cash Flow -0.12
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android